K-924 Phase III Long Term Study
NCT04289662
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypercholesterolemia
Interventions
DRUG:
K-924 LD
DRUG:
K-924 HD
Sponsor
Kowa Company, Ltd.